Iris Medicine Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Iris Medicine is a biotechnology research company pursuing a novel RNA modality called small binding RNAs, or sbRNAs. The sbRNA approach is designed to modulate RNA activity in cells and enables several therapeutic strategies, including allele-selective inhibition, gene activation, and splicing modulation. The firm aims to address a range of serious diseases, beginning with disorders driven by repeat expansions. Its headquarters are in Berkeley, California, and the company describes itself as a small to mid-sized research organization. Within the biotechnology research sector, Iris Medicine focuses on translating RNA-based mechanisms into potential therapies for repeat expansion disorders.